Suchergebnisse - "1756-8919" OR "1756-8927"

PubPharm (3.218)

2221

Modulators of the human ABCC2 : hope from natural sources?

enthalten in: Future medicinal chemistry | 2015

von Baiceanu, E. | Crisan, G. | Loghin, F. | +1

2222

Professional translational research : a new hybrid paradigm in early drug discovery

enthalten in: Future medicinal chemistry | 2015

von Nussbaumer, P. | Klebl, B.

2223

Modifying natural antimicrobial peptides to generate bioinspired antibiotics and devices

enthalten in: Future medicinal chemistry | 2015

von de Castro, A. | Franco, O.

2224

New more polar symmetrical bipyridinic compounds : new strategy for the inhibition of choline kinase α1

enthalten in: Future medicinal chemistry | 2015

von Castro-Navas, F. | Schiaffino-Ortega, S. | Carrasco-Jimenez, M. | +9

2225

Identification of two benzopyrroloxazines acting as selective GPER antagonists in breast cancer cells and cancer-associated fibroblasts

enthalten in: Future medicinal chemistry | 2015

von Maggiolini, M. | Santolla, M. | Avino, S. | +4

2226

In vitro and ex vivo evaluation of biomaterials' distinctive properties as a result of thiolation

enthalten in: Future medicinal chemistry | 2015

von Laffleur, F. | Wagner, J. | Mahmood, A.

2227

Targeting bacterial topoisomerase I to meet the challenge of finding new antibiotics

enthalten in: Future medicinal chemistry | 2015

von Tse-Dinh, Y.

2228

AMPA receptor-positive allosteric modulators for the treatment of schizophrenia : an overview of recent patent applications

enthalten in: Future medicinal chemistry | 2015

von Ward, S. | Pennicott, L. | Beswick, P.

2229

Biofilm formation mechanisms and targets for developing antibiofilm agents

enthalten in: Future medicinal chemistry | 2015

von Rabin, N. | Zheng, Y. | Opoku-Temeng, C. | +3

ErratumIn: Future Med Chem. 2015;7(10):1362. - PMID 26000777

2230

Challenges and opportunities toward enabling phenotypic screening of complex and 3D cell models

enthalten in: Future medicinal chemistry | 2015

von Horman, S. | Hogan, C. | Delos Reyes, K. | +2